Información del producto
- (2S)-N-[(2S)-3-(2-amino-1,3-thiazol-4-yl)-1-[[(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl]amino]-1-oxopropan-2-yl]-2-(morpholin-4-ylsulfonylamino)-3-phenylpropanamide
- N-(4-Morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-((1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-L-alaninamide
- N-(4-Morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-(1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-L-alaninamide
- L-Alaninamide, N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-((1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-
- N-[(2S)-3-(2-amino-1,3-thiazol-4-yl)-2-{[(1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]amino}propanoyl]-Nalpha-(morpholin-4-ylsulfonyl)-L-phenylalaninamide
Applications CI-992, is a novel potent orally active renin inhibitor, that has been proved to be effective on blood pressure on normotensive and hypertensive monkeys. It is also a derivative of Zankiren (Z148060).
References Ryan, M. J., et al.: J. Pharmaco. Exp. Therap., 268, 372 (1994);
Propiedades químicas
Consulta técnica sobre: TR-C432725 CI-992
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.